author-photo

Joe Coffie

2

Papers

9

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

A phase 1b/2, open label, dose-escalation study of margetuximab (M) in combination with pembrolizumab (P) in patients with relapsed/refractory advanced HER2+ gastroesophageal (GEJ) junction or gastric (G) cancer.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (9)
Project Managers Influence Parallel Planning and Collaboration Between Sites and Sponsors

2016 Clinical researcher
Show All
- Source
- Cite
- Save
Citations (0)